Global Adhesion Barrier Market Opportunities and Forecast 2023-2030

Adhesion Barrier Market Overview

Adhesion barriers are used to reduce abnormal internal damage after surgery by separating the internal organs and tissues. The global Adhesion Barrier market is expected to rise at a significate rate in the forthcoming years. A large number of abdominal surgeries are performed worldwide and the demand for adhesion barriers in this vertical has always remained high. As well, their adoption in gynecological surgeries is projected to witness a tremendous surge in the forthcoming years. These factor are expected to fuel the growth of the global Adhesion Barrier market.  Moreover, these barriers are used in abdominal, cardiovascular, gynecological, orthopedic, urological, and reconstructive surgeries. In addition, nearly 90% of patients who undergo abdominal surgery, especially laparotomy, tend to develop abdominal adhesion. This fact further supports the growth of the global Adhesion Barrier market.

Furthermore, a small number of patients who undergo laparoscopic surgery tend to develop abdominal adhesion. Around 10% of those with no history of abdominal surgery also develop abdominal adhesion. This fact also helps to boost the growth of the Adhesion Barrier market. Additionally, increasing adoption of adhesion barrier products, rise in partnerships and collaborations to improve product availability, and growing prevalence of gynecological disorders across the world are anticipated to propel the global Adhesion Barriers market during the forecast period.

On the downside, factors such as strict regulations and legislation for Premarket Approval (PMA) and the application of adhesion barriers are only limited to some specific surgical procedures that may be hampering the growth of the adhesion barriers market.

Covid-19 Impact on Adhesion Barrier Market:

In addition, the current Adhesion Barrier Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Adhesion Barrier Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Adhesion Barrier Market Segment Overview

Based on product, the Seprafilm segment dominated the global Adhesion Barriers market. This is because it has been clinically proven to be effective at reducing post-operative adhesion. Seprafilm is a bioresorbable membrane. It is specified for use in pelvic or abdominal open surgeries to reduce postoperative adhesions. In addition, Seprafilm is a strong brand and widely used product for gynecological surgeries in developed countries such as Japan, Australia, and South Korea. As well, a large share of the product is attributed to easy availability and deep penetration.

Adhesion Barrier Market, By Product

·       Seprafilm
·       Gynecare Interceed
·       Adept
·       Duragen Plus
·       MediShield
·       Oxiplex
·       SprayShield
·       4DryFieldPH
·       Hyalobarrier
·       Others

Adhesion Barrier Market, By Application

·       Gynecological Surgeries
·       Abdominal Surgeries
·       Neuro & Orthopedic Surgeries

Adhesion Barrier Market, By End User

·       Ambulatory Surgical Centers
·       Hospitals
·       Specialty Clinics

Adhesion Barrier Market, By Formulation

·       Liquid
·       Film
·       Gel

Adhesion Barrier Regional Overview

In terms of region, North America accounted for the largest share of the global adhesion barriers market. Important factors such as early adoption of technologically advanced adhesion barrier products, favorable health care reimbursement policies, and increasing the number of surgeries in this region are boosting the growth of the adhesion barriers market in North America. Similarly, Europe is also an attractive market for adhesion barriers. Likewise, the market in the Asia Pacific is projected to grow at a significant rate during the forecast period. This can be attributed to the rising adoption of adhesion barrier products and a high number of gynecological and abdominal surgeries performed in countries such as China, India, and South Korea.

Adhesion Barrier Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Adhesion Barrier Market Competitor overview

Some key developments and strategies adopted by manufacturers in Adhesion Barrier are highlighted below.

·       In October 2018, FzioMed announced the launch of a new anti-adhesion product Oxiplex/IU®. It CE marked and available in the European Union. It is an absorbable, synthetic viscoelastic gel that is applied following intrauterine surgery to preserve uterine integrity and improve surgical outcomes by reducing post-surgical adhesions.

Adhesion Barrier Market, Key Players

·       Baxter International, Inc.
·       Ethicon US, LLC
·       FzioMed, Inc.
·       Sanofi
·       Integra LifeSciences Corporation
·       Anika Therapeutics, Inc.
·       PlantTec Medical GmbH